Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D Carson

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Theranostics|August 24, 2012
The MUC1 Ectodomain: A Novel and Efficient Target for Gold Nanoparticle Clustering and Vapor Nanobubble GenerationBrian P Danysh, Pamela E Constantinou, Ekaterina Y Lukianova-Hleb, et al.
Molecular Endocrinology (Baltimore, Md.)|June 3, 2006
Progesterone receptor isoforms A and B differentially regulate MUC1 expression in uterine epithelial cellsMelissa J Brayman, JoAnne Julian, Biserka Mulac-Jericevic, et al.
The Journal of Biological Chemistry|November 25, 2003
Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasionJane Reiland, Ralph D Sanderson, Marian Waguespack, et al.
Plos One|May 16, 2020
SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture modelsFabio Henrique Brasil da Costa, Michael S Lewis, Anna Truong, et al.
Journal of Cellular Biochemistry|February 8, 2005
Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathwayRania Al-Shami, Esben S Sorensen, Barbro Ek-Rylander, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|December 30, 2006
Global growth deficiencies in mice lacking the ribosomal protein HIP/RPL29Catherine B Kirn-Safran, Daniel S Oristian, Richard J Focht, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2002
Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain IMargaret M French, Ronald R Gomes, Rupert Timpl, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|January 23, 2002
Changes in the cytologic distribution of heparin/heparan sulfate interacting protein/ribosomal protein L29 (HIP/RPL29) during in vivo and in vitro mouse mammary epithelial cell expression and differentiationCatherine B Kirn-Safran, Joanne Julian, Jennifer E Fongemie, et al.
Tissue Engineering|August 8, 2006
Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matricesWeidong Yang, Ronald R Gomes, Anissa J Brown, et al.
Differentiation; Research in Biological Diversity|July 20, 2005
Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytesJacqueline T Hecht, Elizabeth Hayes, Richard Haynes, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Theranostics|August 24, 2012
The MUC1 Ectodomain: A Novel and Efficient Target for Gold Nanoparticle Clustering and Vapor Nanobubble GenerationBrian P Danysh, Pamela E Constantinou, Ekaterina Y Lukianova-Hleb, et al.
Molecular Endocrinology (Baltimore, Md.)|June 3, 2006
Progesterone receptor isoforms A and B differentially regulate MUC1 expression in uterine epithelial cellsMelissa J Brayman, JoAnne Julian, Biserka Mulac-Jericevic, et al.
The Journal of Biological Chemistry|November 25, 2003
Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasionJane Reiland, Ralph D Sanderson, Marian Waguespack, et al.
Plos One|May 16, 2020
SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture modelsFabio Henrique Brasil da Costa, Michael S Lewis, Anna Truong, et al.
Journal of Cellular Biochemistry|February 8, 2005
Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathwayRania Al-Shami, Esben S Sorensen, Barbro Ek-Rylander, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|December 30, 2006
Global growth deficiencies in mice lacking the ribosomal protein HIP/RPL29Catherine B Kirn-Safran, Daniel S Oristian, Richard J Focht, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2002
Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain IMargaret M French, Ronald R Gomes, Rupert Timpl, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|January 23, 2002
Changes in the cytologic distribution of heparin/heparan sulfate interacting protein/ribosomal protein L29 (HIP/RPL29) during in vivo and in vitro mouse mammary epithelial cell expression and differentiationCatherine B Kirn-Safran, Joanne Julian, Jennifer E Fongemie, et al.
Tissue Engineering|August 8, 2006
Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matricesWeidong Yang, Ronald R Gomes, Anissa J Brown, et al.
Differentiation; Research in Biological Diversity|July 20, 2005
Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytesJacqueline T Hecht, Elizabeth Hayes, Richard Haynes, et al.
Pageof 8